|
1
|
Miner JH and Yurchenco PD: Laminin
functions in tissue morphogenesis. Annu Rev Cell Dev Biol.
20:255–284. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marinkovich MP: Laminin 332 in
squamous-cell carcinoma. Nature Rev Cancer. 7:370–380. 2007.
View Article : Google Scholar
|
|
3
|
Ii M, Yamamoto H, Taniguchi H, Adachi Y,
Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, et
al: Co-expression of laminin β3 and γ2 chains and epigenetic
inactivation of laminin α3 chain in gastric cancer. Int J Oncol.
39:593–599. 2011.PubMed/NCBI
|
|
4
|
Guess CM and Quaranta V: Defining the role
of laminin-332 in carcinoma. Matrix Biol. 28:445–455. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamashita H1, Tripathi M, Harris MP, Liu
S, Weidow B, Zent R and Quaranta V: The role of a recombinant
fragment of laminin-332 in integrin α3β1-dependent cell binding,
spreading and migration. Biomaterials. 31:5110–5121. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oka T, Yamamoto H, Sasaki S, Ii M, Hizaki
K, Taniguchi H, Adachi Y, Imai K and Shinomura Y: Overexpression of
β3/γ2 chains of laminin-5 and MMP7 in biliary cancer. World J
Gastroenterol. 15:3865–3873. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wozniak MA, Modzelewska K, Kwong L and
Keely PJ: Focal adhesion regulation of cell behavior. Biochim
Biophys Acta. 1692:103–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kariya Y, Kariya Y and Gu J: Roles of
laminin-332 and alpha6beta4 integrin in tumor progression. Mini Rev
Med Chem. 9:1284–1291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kariya Y and Miyazaki K: The basement
membrane protein laminin-5 acts soluble cell motility factor. Exp
Cell Res. 297:508–520. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nikolopoulos SN, Blaikie P, Yoshioka T,
Guo W, Puri C, Tacchetti C and Giancotti FG: Targeted deletion of
the integrin beta4 signaling domain suppresses laminin-5-dependent
nuclear entry of mitogenactivated protein kinases and NF-kappaB,
causing defects in epidermal growth and migration. Mol Cell Biol.
25:6090–6102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Junior Marangon H, Rocha VN, Leite CF, de
Aguiar MC, Souza PE and Horta MC: Laminin-5 gamma 2 chain
expression is associated with intensity of tumor budding and
density of stromal myofibroblasts in oral squamous cell carcinoma.
J Oral Pathol Med. 43:199–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takahashi S, Hasebe T, Oda T, Sasaki S,
Kinoshita T, Konishi M, Ochiai T and Ochiai A: Cytoplasmic
expression of laminin gamma2 chain correlates with postoperative
hepatic metastasis and poor prognosis in patients with pancreatic
ductal adenocarcinoma. Cancer. 94:1894–1901. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen J, Wang W, Wei J, Zhou D, Zhao X,
Song W, Sun Q, Huang P and Zheng S: Overexpression of β3 chains of
laminin-332 is associated with clinicopathologic features and
decreased survival in patients with pancreatic adenocarcinoma. Appl
Immunohistochem Mol Morphol. 23:516–521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) methods. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang S, Li L and Lin H: A multianalysis
study on clinicopathologic factors related to lymph node metastasis
in gastric cancer. Chin J Oncol. 23:399–402. 2001.
|
|
16
|
Zhao Y and Simon R: BRB-array tools data
archive for human cancer gene expression: A unique and efficient
data sharing resource. Cancer Inform. 6:9–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bernard P1, Antonicelli F, Bedane C, Joly
P, Le Roux-Villet C, Duvert-Lehembre S, Rousselle P and
Prost-Squarcioni C: Prevalence and clinical significance of
anti-laminin 332 autoantibodies detected by a novel enzyme-linked
immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol.
149:533–540. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oh KH, Choi J, Woo JS, Baek SK, Jung KY,
Koh MJ, Kim YS and Kwon SY: Role of laminin 332 in lymph node
metastasis of papillary thyroid carcinoma. Auris Nasus Larynx.
44:729–734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pelissier-Rota M, Chartier NT, Bonaz B and
Jacquier-Sarlin MR: A crosstalk between muscarinic and CRF2
receptors regulates cellular adhesion properties of human colon
cancer cells. Biochim Biophys Acta. 1864:1246–1259. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carpenter PM, Sivadas P, Hua SS, Xiao C,
Gutierrez AB, Ngo T and Gershon PD: Migration of breast cancer cell
lines in response to pulmonary laminin 332. Cancer Med. 6:220–234.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hao J, Jackson L, Calaluce R, McDaniel K,
Dalkin BL and Nagle RB: Investigation into the mechanism of the
loss of laminin 5(alpha3beta3gamma2) expression in prostate cancer.
Am J Pathol. 158:1129–1135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sathyanarayana UG, Toyooka S, Padar A,
Takahashi T, Brambilla E, Minna JD and Gazdar AF: Epigenetic
inactivation of laminin-5-encoding genes in lung cancers. Clin
Cancer Res. 9:2665–2672. 2003.PubMed/NCBI
|
|
23
|
Sathyanarayana UG, Padar A, Huang CX,
Suzuki M, Shigematsu H, Bekele BN and Gazdar AF: Aberrant promoter
methylation and silencing of laminin-5-encoding genes in breast
carcinoma. Clin Cancer Res. 9:6389–6394. 2003.PubMed/NCBI
|
|
24
|
Sathyanarayana UG, Padar A, Suzuki M,
Maruyama R, Shigematsu H, Hsieh JT, Frenkel EP and Gazdar AF:
Aberrant promoter methylation of laminin-5-encoding genes in
prostate cancers and its relationship to clinicopathological
features. Clin Cancer Res. 9:6395–6400. 2003.PubMed/NCBI
|
|
25
|
Sathyanarayana UG, Maruyama R, Padar A,
Suzuki M, Bondaruk J, Sagalowsky A, Minna JD, Frenkel EP, Grossman
HB, Czerniak B and Gazdar AF: Molecular detection of noninvasive
and invasive bladder tumor tissues and exfoliated cells by aberrant
promoter methylation of laminin-5 encoding genes. Cancer Res.
64:1425–1430. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Akimoto S, Nakanishi Y, Sakamoto M, Kanai
Y and Hirohashi S: Laminin 5 beta3 and gamma2 chains are frequently
coexpressed in cancer cells. Pathol Int. 54:688–692. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamada M, Koshikawa N, Mineqishi T, Kawada
C, Karashima T, Shuin T and Seiki M: Urinary laminin-γ2 is a novel
biomarker of non-muscle invasive urothelial carcinoma. Cancer Sci.
106:1730–1737. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Okado Y, Aoki M, Hamasaki M, Koga K, Sueta
T, Shiratsuchi H, Oda Y, Nakagawa T and Nabeshima K: Tumor budding
and laminin5-γ2 in squamous cell carcinoma of the external auditory
canal are associated with shorter survival. Springerplus.
4:8142015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ito E, Ozawa S, Kijima H, Kazuno A, Miyako
H, Nishi T, Chino O, Shimada H, Tanaka M, Inoue S, et al:
Clinicopathological significance of laminin-5γ2 chain expression in
superficial esophageal cancer. Dis Esophagus. 27:463–469. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Masuda R, Kijima H, Imamura N, Aruga N,
Nakazato K, Oiwa K, Nakano T, Watanabe H, Ikoma Y, Tanaka M, et al:
Laminin-5γ2 chain expression is associated with tumor cell
invasiveness and prognosis of lung squamous cell carcinoma. Biomed
Res. 33:309–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xue LY, Zou SM, Zheng S, Liu XY, Wen P,
Yuan YL, Lin DM and Lu N: Expressions of the γ2 chain of laminin-5
and secreted protein acidic and rich in cysteine in esophageal
squamous cell carcinoma and their relation to prognosis. Chin J
Cancer. 30:69–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haas KM, Berndt A, Stiller KJ, Hyckel P
and Kosmehl H: A comparative quantitative analysis of laminin-5 in
the basement membrane of normal, hyperplastic and malignant oral
mucosa by confocal immunofluorescence imaging. J Histochem
Cytochem. 49:1261–1268. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang SG, Ha YR, Ko YH, Kang SH, Joo KJ,
Cho HY, Park HS, Kim CH, Kwon SY, Kim JJ, et al: Effect of laminin
332 on motility and invasion in bladder cancer. Kaohsiung J Med
Sci. 29:422–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rahman F, Rao NN, Tippu SR, Patil S,
Agarwal S and Srivastava S: The expression of laminin-5 in severe
dysplasia/carcinoma in situ and early invasive squamous cell
carcinoma: An immunohistochemical study. Minerva Stomatol.
62:139–146. 2013.PubMed/NCBI
|
|
35
|
Kinoshita T, Hanazawa T, Nohata N, Kikkawa
N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto
Y and Seki N: Tumor suppressive microRNA-218 inhibits cancer cell
migration and invasion through targeting laminin-332 in head and
neck squamous cell carcinoma. Oncotarget. 3:1386–1400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miyazaki K: Laminin-5 (laminin-332):
Unique biological activity and role in tumor growth and invasion.
Cancer Sci. 97:91–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tani T, Lumme A, Linnala A, Kivilaakso E,
Kiviluoto T, Burgeson RE, Kangas L, Leivo I and Virtanen I:
Pancreatic carcinomas deposit laminin-5, preferably adhere to
laminin-5 and migrate on the newly deposited basement membrane. Am
J Pathol. 151:1289–1302. 1997.PubMed/NCBI
|
